Skip to main content
OpenTrials
Completed

NCT Number: NCT01806935

Xerotic Dermatitis in Aged People

The purpose of the study is to assess the the effect of the study product on itching symptoms associated with xerotic dermatitis in aged population

Completed

Looking for future studies?

Notify Me

Key information

Age range

70 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

0521, Angers, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged from 70 years
  • With xerotic dermatitis, clinically assessed ,
  • At least on the anterior part of lower and/or upper limbs,
  • Presenting itching xerotic dermatitis evolving from at least 3 weeks
  • Intensity of itching ≥ 4 on VAS (0-10) at th inclusion time
  • With MMSE score ≥ 20 dating less than 6 months
  • Affiliated to a social security system, or is a beneficiary (as applicable in the national regulation)

Exclusion criteria

  • Criteria related to pathologies
  • Severe form of other dermatitis requiring either systemic treatment

-- Itching xerotic dermatitis from iatrogenic origins

  • Dermatological disease other than xerotic dermatitis which could interfere with the assessment,
  • Systemic disease that may generate xerotic dermatitis and /or pruritus
  • Immunosuppression condition,
  • History of serious disease considered by the investigator hazardous for the patient or incompatible with the study.
  • Criteria related to treatment
  • Use of treatment which could interfere with the evaluation of the disease or the course of the disease
  • Criteria related to the population
  • Ongoing participation to another clinical trial or participation in the previous month before the inclusion
  • Patient under guardianship or trusteeship

Treatment and study plan

DC086

Device

PLACEBO

Device

Primary outcomes

  1. Itching symptoms intensity change

    Time frame: From Day 1 to 28 days

Sponsors and collaborators

Lead sponsor

Pierre Fabre Medical Devices

Industry

Registry information

Important dates

Study start
2013
Primary completion
2013
Study completion
2013
First posted
Mar 7, 2013
Registry last updated
Sep 26, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.